Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder

Journal of Psychiatric Research

Volumn 30, Issue 3, 1996, Pages 147-168

  Piletz, John E ^a   Halaris, Angelos ^a   Nelson, Jill ^a   Qu, Yinsheng ^b   Bari, Mohammed ^c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Vista Hill Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CLONIDINE; DESIPRAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMIDAZOLINE; MOXONIDINE; NORADRENALIN; BIOLOGICAL MARKER; DRUG RECEPTOR; IMIDAZOLINE RECEPTORS;

ADULT; ANXIETY NEUROSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DISEASE SEVERITY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; HAMILTON SCALE; HUMAN; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; THROMBOCYTE; ANXIETY DISORDER; BLOOD; CHEMISTRY; DRUG EFFECT; METABOLISM; MIDDLE AGED;

ADULT; ANXIETY DISORDERS; BINDING SITES; BIOLOGICAL MARKERS; BLOOD PLATELETS; CLONIDINE; DEPRESSIVE DISORDER; DESIPRAMINE; FEMALE; GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG;

EID: 0030131588     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-3956(96)00005-2     Document Type: Article

References (72)

1. Atlas, D. (1991). Clonidine-displacing substance (CDS) and its putative imidazoline receptor. Biochemical Pharmacology, 41, 1541-1549.
2. Bousquet, P., Feldman, J., Bloch, R., & Schwartz, J. (1981). The nucleus reticularis lateralis: a region highly sensitive to clonidine. European Journal of Pharmacology, 84, 389-392.
3. Bousquet, P., Feldman, J., Bloch, R., & Schwartz, J. (1984). Central cardiovascular effects of alpha-adrenergic drugs; differences between catecholamines and imidazolines. Journal of Pharmacology and Experimental Therapeutics, 230, 232-236.
4. Bunney, W. E. Jr., & Davis, J. M. (1965). Norepinephrine in depressive reactions: a review. Archives of General Psychiatry, 13, 483-494.
5. Bylund, D. S., Blaxall, H. S., Iversen, L. J., Caron, M. G., Lefkowitz, R. J., & Lomasney, J. W. (1992). Pharmacological characteristics of α-2 adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Molecular Pharmacology, 42, 1-5.
6. 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Biological Psychiatry, 28, 3-20.
7. Campbell, I., McWilliam, J. R., & Adamson, P. (1987). Central adrenergic receptors. Psychopharmacology, 2, 55-66.
8. Crews, F. T., & Smith, C. B. (1978). Presynaptic α-receptor subsensitivity after long-term antidepressant treatment. Science, 202, 322-324.
9. Da Prada, M., Cesura, A. M., Launay, J. M., & Richards, J. G. (1988). Platelets as a model for neurons? Experientia, 44, 115-126.
10. Davies, I. B., Sudera, D., & Sever, P. S. (1981). Endogenous agonist regulation of alpha-adrenoceptors in man. Clinical Sciences, 61, 207s-210s.
11. Diamant, S., Eldor, A., & Atlas, D. (1987). A low molecular weight brain substance interacts, similarly to clonidine, with α2-adrenoceptors of human platelets. European Journal of Pharmacology, 144, 247-255.
12. Doyle, M. C., George, A. J., Ravindran, A. V., & Phillpot, R. (1985). Platelet α-2 adrenoceptor binding in elderly depressed patients. American Journal of Psychiatry, 142, 1489-1490.
13. Ernsberger, P., Giuliano, R., Willette, R. N., & Reis, D. J. (1990). Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. Journal of Pharmacology and Experimental Therapeutics, 253, 408-418.
14. Ernsberger, P., Meeley, M. P., Mann, J. J., & Reis, D. J. (1987). Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla. European Journal of Pharmacology, 134, 1-13.
15. 1-imidazoline sites. Annals of New York Academy of Science, 763, 163-168.
16. Garcia-Sevilla, J. A. (1989). The platelet α2-adrenoceptor as a potential biological marker in depression. British Journal of Psychiatry, 154, 67-72.
17. Garcia-Sevilla, J. A., Guimon, J., Garcia-Vallejo, P., & Fuster, M. J. (1986). Biochemical and functional evidence of supersensitive platelet α-2 adrenoceptors in major affective disorder. Archives of General Psychiatry, 43, 51-57.
18. 3H-yohimbine and competitive inhibition by antidepressant drugs. European Journal of Pharmacology, 74, 329-341.
19. Garcia-Sevilla, J. A., Zis, A. P., Hollingsworth, P. J., Greden, J. F., & Smith, C. B. (1981). Platelet α-2 adrenergic receptors in major depressive disorder. Archives of General Psychiatry, 38, 1327-1333.
20. 3H-imipramine binding in elderly depressed patients. Life Science, 40, 2137-2143.
21. Glossman, H., & Presek, P. (1979). Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding. Naunyn-Schmiedeberg's Archives of Pharmacology, 306, 67-73.
22. Grossman, F., Manji, H. K., & Potter, W. Z. (1993). Platelet α-2 adrenoceptors in depression: a critical examination. Journal of Psychopharmacology, 7, 4-18.
23. Halbreich, U., Plietz, J. E., Carson, S., Halaris, A., & Rojansky, N. (1993). Increased imidazoline and α-2 adrenergic binding in platelets of women with dysphoric premenatrual syndromes. Biological Psychiatry, 34, 676-686.
24. Hamilton, M. (1967). Development of a rating scale for primary depression. British Journal of Sociology and Psychology, 6, 278-296.
25. Hancock, A. A., Bush, E. N., Stanistic, D., Kynel, J. J., & Lin, C. T. (1988). Data normalization before statistical analysis; keeping the horse before the cart. Trends in Pharmacological Sciences, 9, 29-32.
26. Kafka, M. S., & Paul, S. M. (1986). Platelet α-2 adrenergic receptors in depression. Archives of General Psychiatry, 43, 91-95.
27. 3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain. Brain Research, 514, 15-21.
28. Karege, F., Bovier, P., Widmer, J., Gaillard, J. M., & Tissot, R. (1992). Platelet membrane α2-adrenergic receptors in depression. Psychiatry Research, 43, 243-252.
29. Lehmann, J., Koenig-Berard, E., & Vitou, P. (1989). The imidazoline-preferring receptor. Life Science, 45, 1609-1615.
30. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., & Reis, D. J. (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
31. Manji, H. K., Rudorfer, M. V., & Potter, W. Z. (1994). Affective disorders and adrenergic function. In O. G. Cameron (Ed.), Adrenergic dysfunction and psychobiology (pp. 365-401). American Psychiatric Press, Washington, D.C.
32. McPherson, C. A. (1985). Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. Journal of Pharmacological Methods, 14, 213-228.
33. Meeley, M. P., Ernsberger, P., Char, L. K., Noponen, M., & Reis, D. J. (1989). Regional and subcellular distribution of clonidine-displacing substance in brain. Society for Neuroscience Abstracts, 15, 1179.
34. Meeley, M. P., Hensley, M. L., Ernsberger, P., Felsen, D., & Reis, D. J. (1992). Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum. Biochemical Pharmacology, 44, 733-740.
35. Mendlewicz, J., Hirsch, D., Sevy, S., Surmont, D., Papadimitriou, G., & De Maertelaer, V. (1989). Alpha-2-adrenoreceptor binding as a possible vulnerability marker for affective disorders. Neuropsychobiology, 22, 61-67.
36. Michel, M. C., & Ernsberger, P. (1992). Keeping an eye on the I site: imidazoline-preferring receptors. Trends in Pharmacological Sciences, 13, 369-370.
37. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's Archives of Pharmacology, 348, 70-76
38. Murphy, D. L., Campbell, I., & Costa, J. L. (1978). Current status of the indoleamine hypothesis of the affective disorders. In M. A. Lipton, A. DiMascio & K. F. Killam (Eds), Psychopharmacology: a generation of progress (pp. 1223-1334). New York: Raven Press..
39. Nasseri, A., & Minneman, K. P. (1987). Relationship between α-2 adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex. Molecular Pharmacology, 32, 655-662.
40. Neubig, R. R., & Szamraj, O. (1986) Large-scale purification of α2-adrenergic receptor-enriched membranes from human platelets. Persistent association of guanine nucleotides with nonpurified membranes. Biochemical Biophysical Acta, 854, 67-76.
41. Nyberg, G., & Martensson, E. (1986). Preparation of serum and plasma samples for determination of tricyclic antidepressants: effects of blood collection tubes and storage. Therapeutic Drug Monitoring, 8, 478-482.
42. 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiatry Research, 28, 73-88.
43. 2-adrenergic receptors. Society for Neuroscience Abstracts, 19, 233.
44. 3H]-p-aminoclonidine to α2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochemical Pharmacology, 42, 569-584.
45. Piletz, J. E., Chikkala, D., & Ernsberger, P. (1995) Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. Journal of Pharmacology and Experimental Therapeutics, 272, 581-587.
46. Piletz, J. E., Chikkala, D., Khaitan, L., Jackson, K., & Qu, Y. S. (1993). Delayed desensitization of α-2 adrenoceptor-mediated platelet aggregation in depressed patients. Neuropsychopharmacology, 9, 55-66.
47. 3H-para-aminoclonidine binding to different platelet preparations. Journal of Neural Transmission, 82, 11-29.
48. 2-adrenergic receptors: implications for depression. Critical Reviews in Neurobiology, 9, 29-66.
49. 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients. Neuropsychopharmacology, 3, 201-210.
50. 3H-para-aminoclonidine binding in platelets of depressed patients. Archives of General Psychiatry, 48, 813-820.
51. Piletz, J. E., Schubert, D. S. P., & Halaris, A. (1986). Evaluation of studies of platelet α-2 adrenoceptors in depressive illness. Life Science, 39, 1589-1616.
52. Piletz, J. E., & Sletten, K. (1993). Nonadrenergic imidazoline binding sites on human platelets. Journal of Pharmacology and Experimental Therapeutics, 267, 1493-1502.
53. Pletscher, A. (1988). Platelets as models: use and limitations. Experientia, 44, 152-155.
54. Raiteri, M., Maura, G., Folghera, S., Cavazzani, P., Andrioli, G. C., Schlicker, E., Schalnus, R., & Gothert, M. (1990). Modulation of 5-hydroxytryptamine release by presynaptic inhibitory α2-adrenoceptors in the human cerebral cortex. Naunyn-Schmiedeberg's Archives of Pharmacology, 342, 508-512.
55. Regunathan, S., Meeley, M. P., & Reis, D. J. (1991). Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells. Molecular Pharmacology, 40, 884-888.
56. Reis, D. J., Regunathan, S., & Meeley, M. P. (1992). Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion. American Journal of Hypertension, 5, 51S-57S.
57. Roy, A., Guthrie, S., Pickar, D., & Linnoila, M. (1987). Plasma norepinephrine responses to cold challenge in depressed patients and normal subjects. Psychiatry Research, 21, 161-168.
58. Roy, A., & Kafka, M. S. (1989). Platelet adrenoceptors and prostaglandin responses in depressed patients. Psychiatry Research, 30, 181-189.
59. Sacchetti, E., Conte, G., Pennati, A., Alciati, A., & Cazzullo, C. L. (1985). Platelet α-2 adrenoceptors in major depression: relationship with urinary 4-hydroxy-3-methoxyphenylglycol and age at onset. Psychiatry Research, 19, 579-586
60. SAS Institute Inc. (1985). SAS user's guide: basics and statistics. 1985 Edition. Gary NC: SAS Institute Inc.
61. Schildkraut, J. J. (1978). Current status of the catecholamine hypothesis of affective disorders. In M. A. Lipton, K. F. Dimascio & K. F. Killam (Eds), Psychopharmacology: a generation of progress (pp. 1223-1234). New York: Raven Press..
62. Sevy, S., Papadimitriou, G. N., Surmont, D. W., Goldman, S., & Mendlewicz, J. (1989). Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Biological Psychiatry, 25, 141-152.
63. Smith, C. B., Hollingsworth, P. J., Garcia-Sevilla, J. A., & Zis, A. P. (1983). Platelet alpha-2 adrenoceptors are decreased in number after antidepressant therapy. Progress in Neuropsychopharmacology and Biological Psychiatry, 7, 241-247.
64. Synetos, D., Manolopoulos, V. G., Atlas, D., & Pipili-Synetos, E. (1991). Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aorta. Journal of Autonomic Pharmacology, 11, 343-351.
65. 3H-imipramine binding and plasma cortisol levels in depression. Biological Psychiatry, 26, 52-60.
66. Tesson, F., Prip-Buus, C., Lemoine, A., Pegorier, J.-P., & Parini, A. (1991). Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver: major localization to the mitochondrial outer membrane. Journal of Biological Chemistry, 266, 155-160.
67. 3H]UK-14,304 in depressed patients and matched controls. European Journal of Pharmacology, 126, 329-332.
68. Theodorou, A. E., Lawrence, K. M., Healy, D., Whitehouse, A. M., White, W., Cox, H. W., Kerry, S. M., Horton, R. W., & Paykel, E. S. (1991). Platelet α2-adrenoceptors, defined with agonist and antagonist ligands, in depressed patients, prior to and following treatment. Affective Disorders, 23, 99-106.
69. Tibirica, E., Feldman, J., Mermet, C., Gonon, F., & Bousquet, P. (1991). An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. Journal of Pharmacology and Experimental Therapeutics, 256, 606-613
70. U'Prichard, D. C., Loftus, D. J., & Stolk, J. M. (1988). Functional association between epinephrine-containing neurons and α-adrenoceptors in discrete brain areas: Analysis in inbred rat strains. In J. M. Stolk, D. C. U'Prichard & K. Fuxe (Eds), Epinephrine in the central nervous system (pp. 195-212). New YorK: Oxford University Press.
71. Werstiuk, E. S., Auffarth, S. E., Coote, M., Gupta, R. N., & Steiner, M. (1992). Platelet α2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine. Pharmacopsychiatry, 25, 199-206.
72. 3H]-Idazoxan binding sites (I-receptors) occurs at interacting or interconvertible affinity forms of the receptor. Pharmacology and Toxicology, 70, 208-219.